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Abstract
Introduction Canine atopic dermatitis (cAD) is a very common disease, but little is
known about eye involvement. The conjunctival provocation test (CPT) is used in
human to study the ocular response to allergenic stimuli and to evaluate anti-allergic
therapy. To our knowledge it has not been used in dogs.
Objectives To evaluate the prevalence of ocular signs in a population of atopic dogs
and relate these with clinical cAD scores; and the usefulness of CPT for dust mites in
atopic dogs with itchy eyes.
Procedures Sixty cAD patients were evaluated for (i) ocular signs of allergic
conjunctivitis including conjunctival hyperemia, chemosis, epiphora, ocular discharge,
pruritus and corneal involvement, graded 0 to 3 according to severity, and (2) cAD
Extent and Severity Index (CADESI-03). Additionally, CPTs for Dermatophagoides
farinae (n = 12) and Dermatophagoides pteronyssinus (n = 12) were performed in
sensitized atopic dogs and 24 control dogs.
Results Periocular and ocular signs of allergy were present in 60% (36/60) of cases.
Conjunctival hyperemia (90%) was the most common sign. Severity of ocular signs
was significantly correlated with eye pruritus (rs = 0.690, P = <0.001) and skin lesions
score for head region (rs = 0.261, P = 0.04). A highly significant difference (P < 0.001,
Fisher test) was found in CPTs between the test and the control groups.
Conclusion Allergic conjunctivitis signs associated with cAD seem under valuated so
these patients would benefit from an ophthalmologic evaluation. Furthermore, we
found CPT to be a reliable, easy to perform and safe test for the etiologic diagnosis
of allergic conjunctivitis in the dog.
Key Words: allergic conjunctivitis, canine atopic dermatitis, conjunctival provocation
test, Dermatophagoides farinae, Dermatophagoides pteronyssinus, house dust mites
INTRODUCTION
‘Imagine life on the most exposed environment on the
planet – the cornea’.1 In fact, as McMenamin describes in
his inspiring article, the eye is subject to every kind of
external aggression. So, it has developed the ability to
adapt to many environmental changes, and protect itself
from potentially hostile agents such as bacteria and viruses.
Although it does not have lymphatic vessels, still possesses
a rich immune system, ready to interact with antigens.2
An allergic disease is characterized by an exaggerated
response to innocuous antigens, developed by genetically
predisposed individuals. Allergic manifestations tend to
occur where the body is most exposed to agents from the
external environment. In humans the eye is often the target
for allergic reactions.3 Allergic conjunctivitis is the most
common form of eye allergy in human. The term ‘allergic
conjunctivitis’ refers to a collection of hypersensitivity disor-
ders that affect the lid, conjunctiva and/or cornea. Allergic
conjunctivitis ranges in severity from mild to extremely
severe forms, which can interfere significantly with quality
of life and vision, imposing a substantial burden of disease
and medical cost on allergy patients.4 Nevertheless, little
focus is put to the ocular symptoms on their own. According
to some human ophthalmologists the prevalence of ocular
allergy clearly is underappreciated and has been under
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diagnosed and undertreated.2,4,5 Articles titles ‘Allergic
conjunctivitis: the forgotten disease’2 or ‘Prevalence of
allergic conjunctivitis: a missed opportunity’,6 published by
some of the most preeminent researchers in human ophthal-
mology, seem to say it all.
Diagnostic guidelines for the diagnosis of ocular allergic
diseases in human are still inexistent. Mantelli and collabo-
rators just set a new simple diagnostic algorithm to facilitate
identification of the various clinical types of ocular allergic
diseases and allow a more uniform approach to these
patients.7 In the end, although the presumptive diagnosis of
ocular allergy is mainly clinical, the final corroboration
requires allergic testing.8 This is usually done by perform-
ing skin tests or serology to demonstrate sensitivity to one
or more allergens, combined with interviewing the patient.
However, only the conjunctival provocation test (CPT)
provides clear evidence of a etiopathogenic relation
between the conjunctival pathology and exposure to the
allergen.8 This test is also useful to evaluate the antiallergic
therapy efficacy.9 Efforts are being made to lead to the stan-
dardization of the CPT procedure for diagnostic purpose in
human.8
A red eye is a common presentation in all veterinary clini-
cal practices, with conjunctivitis being its most common
cause. Conjunctivitis can be infectious (bacterial and viral),
toxic/irritative or allergic in origin. Other forms of conjunc-
tivitis are rare and related to systemic conditions, such as
autoimmune diseases. Presumptive diagnosis of allergic con-
junctivitis is made by exclusion of other causes of conjuncti-
vitis, history and positive results on allergy testing (serology
or intradermal tests). To our knowledge, we do not have
standardized criteria, available to general practitioners and
that would allow them to correctly and easily diagnose
allergic conjunctivitis in the dog.
Although allergic conjunctivitis can probably exist on its
own, it can also be concurrent to canine atopic dermatitis
(cAD). In fact, the diagnosis of simultaneous cAD and con-
junctivitis is not new.10 Recently, cAD was redefined as a
genetically predisposed inflammatory and pruritic allergic
skin disease with characteristic clinical features associated
with IgE antibodies most commonly directed against envi-
ronmental allergens.11 cAD is clinically and immunolo-
gically similar to human atopic dermatitis.12 The exact
prevalence of cAD remains unknown, but it is estimated, as
in human, to affect around 10% of the population, with
some breeds being more predisposed.13 The definition of
cAD suggests strong breed and/or familial predispositions.
Some dogs with cAD show concomitant nondermatologic
signs, although few studies mentioned their prevalence.
Three studies, done in the early 1980s by veterinarian der-
matologists, found the prevalence of AC associated with
cAD to be around 30%14 and 50%.15,16
The importance given to the ocular signs at that time
must have been significant, as the presence of a bilateral
conjunctivitis was even included as a minor criteria for the
diagnosis of cAD according to Willemse criteria, published
some years later.17 That interest seems to have vanished with
time.
Since then, little has been reported about allergic con-
junctivitis in cAD. In 2001, the American College of
Veterinary Dermatology Task Force on Canine Atopic
Dermatitis published an enlightening review of all that was
known about cAD at that time. In the chapter on clinical
signs it is mentioned that ‘noncutaneous signs associated
with cAD (such as rhinitis, sneezing or conjunctivitis) are
reported to be uncommon or variable in their occurrence’.18
It is also stated that nondermatologic signs of canine atopy
maybe severely underreported.
Earlier this year, Favrot and collaborators published a
study with the characterization of the clinical features and
signs of a large population of dogs (n = 843) with cAD.19
They looked for the presence of spring/summer conjunctivi-
tis associated with cAD and found a prevalence of 21%.
Unfortunately no other ocular signs, such as perennial
conjunctivitis, were reported. Most dogs in Europe have
perennial symptoms, usually due to dust mite (Dermato-
phagoides farinae and/or Dermatophagoides pteronyssinus) sensi-
tization, the most common allergens.20 In this study, the
criteria used for the diagnosis of the allergic conjunctivitis
are not described.
It is possible that allergic conjunctivitis in cAD is also
underreported as seems to be the case in human. Maybe
nondermatologic signs are also sometimes missed or under-
valued as most dogs with cAD are seen by general physicians
or dermatologists and not by ophthalmologists. Also, that
we know of, CPTs have not been used to evaluate the contri-
bution of specific allergens to allergic conjunctivitis in dogs
with spontaneous cAD.
In this prospective study we aimed to (i) evaluate the
prevalence of ocular signs in a population of dogs with cAD
and relate their severity with skin signs, and (ii) to perform
CPT with the dust mites Dermatophagoides farinae and
Dermatophagoides pteronyssinus on a group of patients with
cAD, ocular allergy signs and sensitization to these mites.
This will enable us to establish a relationship between ocular
manifestations and the presence of a clinical relevant sensiti-
zation against these mites.
MATERIALS AND METHODS
The study was conducted in the teaching Hospital of the
Faculty of Veterinary Medicine, Technical University of
Lisbon. All the owners gave informed written consent for
the inclusion of their dogs in the study.
Phase 1 – ‘‘planet eye’’
Patient selection The study is of a prospective nature, and
after it began all patients with cAD that were seen in the der-
matology services were enrolled, after owners consent, inde-
pendent of previous complaints or visits to our Hospital.
Cases were enrolled and evaluated over the year. For each
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dog, diagnosis of cAD was made according to standard crite-
ria.21,22 In summary, combination of (i) compatible history;
(ii) fulfillment of clinical criteria strongly associated with the
disease; (iii) exclusion of other pruritic skin diseases, specifi-
cally: no response to a minimum 8-week diet trial with either
a home-cooked or commercial hydrolyzed protein diet and
water only to eliminate the possibility of an adverse food
reaction; no response to a veterinary approved flea control
regimen for at least 8 weeks; sarcoptic mange excluded by
trial therapy and/or negative serology. In addition, the
occurrence of at least one positive sensitization by intrader-
mal test (IDT) reaction, performed in the skin of the lateral
thorax and interpreted according to accepted criteria that
agreed well with the patient’s history was required. No anti-
inflammatory medication (topical or systemic) was given for
at least 3 weeks prior to examination.
Dermatology Department evaluation All patients under-
went a complete dermatologic evaluation and cAD clinical
lesions were scored using the CADESI-03. This is a vali-
dated evaluation of clinical lesions (erythema, excoriation,
lichenification, and self-induced alopecia) at 62 anatomical
sites, each measured from 0 (normal) to 5 (most severe).23
Proposed intervals by the International Task Force on
Canine Atopic Dermatitis for CADESI-03 are: remission:
0–15; mild AD: 16–59; moderate AD: 60–119; and severe
AD: ‡120.24
Additionally, one investigator (A.M. Martins) assessed if
the dog had or not allergic conjunctivitis according to
personal experience.
Ophthalmology Department evaluation A blinded, com-
plete ophthalmic exam was performed in all dogs that
included:
(1) external observation of the eye, eyelids and the
peribulbar structures with a focal light source.
(2) tear production test assessed using Schirmer I Tear
Test (STT, Dina strips Schirmer-Plus; Luneau SAS,
Chartres, France) strips. Reference values were
between 15 and 25 mm/min.25
(3) palpebral, direct and consensual pupillary reflexes as
well as menace response, dazzle and oculocephalic
reflexes evaluated in a dimly-lit room.
(4) measurement of the intraocular pressure (IOP) by
applanation tonometry (Tono-Pen XL; Medtronic
Solan, Jacksonville, FL, USA) following instillation of
a drop of topical anesthetic (0.4% Oxibuprocaine, An-
estocil; Oftalder, Oeiras, Portugal). Reference values
were between 15 and 25 mmHg.25 The measurements
were repeated three times. The values were considered
valid when the coefficient of variance was 5% and the
mean value was calculated.
(5) slit-lamp biomicroscopy using Kowa SL 15 (Kowa,
Tokyo, Japan) performed in a darkened room. Ocular
signs of allergic conjunctivitis were evaluated, including
conjunctival hyperemia, chemosis, epiphora, ocular
discharge, pruritus and corneal involvement, and graded
0 to 3 according to severity.
(6) funduscopy performed in a darkened room by indirect
ophthalmoscopy (Heine O´mega 500, Herrsching,
Germany) after dilatation of pupils with tropicamide
(Tropicamide 1%, Tropicil Top; Edol, Linda-a-
Velha, Portugal).
(7) conjuctival brush cytology and fluorescein staining
(Fluorescein; Haag-Streit International, Ko¨niz, Swit-
zerland) were performed to exclude other causes of
ocular signs.
During ophthalmic examination ocular signs of allergic
conjunctivitis including conjunctival hyperemia, chemosis,
epiphora, ocular discharge, and corneal involvement were
graded 0 to 3 according to severity.
Additionally, we asked the owners to evaluate their dog’s
pruritus according to the following classification: (0) no ocu-
lar pruritus; (1) mild ocular pruritus; (2) moderate ocular
pruritus; (3) severe ocular pruritus. We have explained the
owners that ocular pruritus can be manifested as ocular
squinting, blepharospasm and attempts to scratch or rub
their eyes with the paws or against objects. Sometimes they
could even develop periocular alopecia as a result of
self-inflicted trauma.
The final clinical score for the severity of the ocular signs
resulted from sum of the individual scores (conjunctival
hyperemia, chemosis, epiphora, ocular discharge, and cor-
neal involvement and ocular pruritus) varying from 0 to 18
(6 · 3).
Phase 2 – conjunctival provocation tests
Patient selection Test Group: From the group of patients
enrolled in phase 1 (Planet eye), 24 dogs with cAD, of which
12 were sensitized for Dermatophagoides farinae (Df) and
other 12 to Dermatophagoides pteronyssinus (Dp), were
selected as the test group. None of the dogs with cAD was
having a flare of its allergy.
Control Group: The control group comprised two
subgroups: (i) with 12 dogs with cAD but no mite sensitiza-
tion on the IDT, and (ii) with 12 healthy dogs. All dogs were
considered normal and bilaterally similar on previous
ophthalmologic examination.
Conjunctival provocation tests To our knowledge there are
currently no guidelines on how to perform CPTs in dogs, so
we followed those for humans and the manufacturer’s
instructions.8 Briefly, we used ALK-Abello´ Dermatophagoides
farinae (Df) and Dermatophagoides pteronyssinus (Dp) lyophi-
lized extract (Aquagen SQ; ALK-Abello´, Bioportugal, Alge´s,
Portugal) and Aquagen specific diluent, water based and
without phenol, to produce a 10 BU/mL. Then, three serial
dilutions of 1:5 were created, using sterile isotonic saline
solution (NaCl 0.9%, B.Braun Medical, Barcarena,
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Portugal) to arrive to the final testing solutions at the con-
centrations of 2, 0.4, and 0.08 BU/mL.
All dogs underwent CPT as follows: aquagen diluent was
used as the negative control and a single drop (50 lL) was
placed in the left conjunctival sac. A drop of successively
stronger testing solutions was placed in the right conjuncti-
val sac at 15-min intervals, each step in the test sequence
being contingent on a negative response in the immediately
preceding step. Fifteen minutes after each drop was instilled,
both eyes were inspected for conjunctival hyperemia,
chemosis and epiphora and each reaction scored as
absent = 0, mild = 1, moderate = 2 or severe = 3. Ocular
pruritus was also evaluated, using a scale with an extra score,
extremely severe = 4. The CPT was considered positive if
the score was equal or higher to 5 (maximum 13) and
implied no further testing. At the end of the test, a drop of
dexametasone acetate in a 0.1% concentration (Dexaval-O;
Tecnifar, Lisboa, Portugal) was instilled in the right eye,
to minimize discomfort and avoid late-onset reactions. All
dogs were monitored for adverse reactions in the following
2 h. The investigator (E. Delgado) was blinded for dogs’
sensitization. Dogs from the control group had the CPT
done for Df and Dp with more than 2 weeks interval in
between.
Statistical analysis
Phase 1 (Planet eye) Descriptive statistics were calculated
for sample description and characterization. Mean ±
standard deviation values for CADESI-03 and ocular score
for the 60 patients of phase 1 ‘‘planet eye’’ are presented.
Spearman Rank correlation was used to assess the relation-
ship between ocular final score results, ocular pruritus, and
severity of head and allover body skin lesions of cAD (evalu-
ated by CADESI-03). Two-tailed Spearman’s rho test was
considered significant when P < 0.05.
Phase 2 (Conjunctival provocation tests) CADESI-03 and
ocular score values for the CPT test group are shown as
mean ± standard deviation. We used Fisher’s exact test (a
nonparametric test of significance) to test differences
between groups of dogs sensitized either for Df or for Dp
and the control subgroups (i) healthy dogs and (ii) cAD dogs.
The data to which this test was applied are counts displayed
in Table 1. Since we did not have an interval dependent
variable, the ANOVA methods (parametric or nonparametric)
could not be used.
Sensitivity, specificity, predictive positive value and
predictive negative value with the respective 95% confidence
intervals were calculated for both diagnostic tests (CPT for
Df and CPT for Dp).
SPSS Statistics Release 17.0 (IBM Corporation, Somers,
NY, USA) for Windows was used for all data analysis
procedures.
RESULTS
Phase 1 – ‘‘planet eye’’
Sixty atopic dogs (n = 60) were selected according to standard
criteria. The patients were enrolled and evaluated over the
year, thereby representing a typical scenario in clinical prac-
tice. The majority of atopic dogs in Europe have all-year long
clinical signs due to house dust mites allergy. Interestingly,
we found out that 14 dogs enrolled in the study, had been
previously sent by their general practitioner to our hospital
ophthalmology service due to ocular pruritus and no primary
eye problem was found. After that, and due to the dermato-
logic complaints, they referred them again, but this time to
the dermatology service. They were at this point evaluated
and after all criteria were checked, enrolled in this study.
Gender distribution was as follows: 45% (27/60) were
females and 55% (33/60) males. The mean age was 5 years
(mean deviation = 2.5). Twenty-one different breeds were
included in a total of 44 purebred animals vs. 16 mongrel
dogs. The most represented breeds were the Labrador
retriever, the Golden retriever, the Yorkshire terrier, the
Cocker spaniel and the Pug. All of these breeds have been
found to have predisposition for atopic dermatitis.26
Mean ± standard deviation values for CADESI-03 and
ocular score for the 60 patients of phase 1 ‘‘planet eye’’ were
respectively 87.2 ± 72.03 and 5.3 ± 2.94.
The most common ocular clinical signs were conjunctival
hyperemia 90% and pruritus 73%, followed by chemosis
70%. Ocular discharge 60%, epiphora 57% and corneal
involvement 10% were less frequent.
The distribution of ocular signs and their relative severity
can be seen in Fig. 1 and examples of these patients in
Figs 2,3.
No signs of severe corneal ulceration (sterile/infective
lesions) were observed in the six patients diagnosed with
corneal involvement. One only presented corneal dystrophy
and five had corneal neovascularization, from which two also
presented punctuate keratitis and stained positive with
fluorescein.
In the allergic conjunctivitis acute cases there was epipho-
ra, conjunctival hyperemia, squinting and a certain degree of
blepharospasm while in the chronic states the animal
evidenced follicular conjunctivitis with hypertrophy of
lymphoid follicles visible in the bulbar conjunctiva and inner
part of the third eyelid as well as the presence of a white
mucus discharge.
Table 1. Conjunctival provocation test results
Subgroup
Positive
CPT (Df)
Positive
CPT (Dp)
Test group cAD sensitized to Dp n.a 10/12
cAD sensitized to Df 11/12 n.a.
Control group Healthy dogs 0/12 0/12
cAD 1/12 1/12
cAD, canine atopic dermatitis; CPT, conjunctival provocation test;
Df, Dermatophagoides farinae; Dp, Dermatophagoides pteronyssinus; n.a.,
Not applicable.
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The prevalence of allergic conjunctivitis varied with the
department: ophthalmology diagnosed 36/60 (60%) and
dermatology only 10/60 (17%). So, dermatology missed to
diagnose 26 cases (72%) of allergic conjunctivitis cases
according to ophthalmologic evaluation.
Evidence of a significant relationship between eye pruri-
tus and final ocular score was found (Spearman correlation
coefficient rs = 0.690; P < 0.001). Skin lesion score for the
region of the head and final ocular score were also signifi-
cantly correlated (rs = 0.261; P = 0.04). However, data
provided no evidence of a relationship between CADESI-03
and final ocular score (rs = )0.024; P = 0.86), which means
that we could not find any association between severe form
of dermatitis and conjunctivitis.
Phase 2 – conjunctival provocation tests
CADESI-03 and ocular score values for the CPT test group
Df are respectively 89.9 ± 85.46 and 3.6 ± 2.02 (shown as
mean ± standard deviation); for Dp group are correspond-
ingly 64.3 ± 41.1 and 4.17 ± 2.62. The results of the CPT
can be observed in Table 1. The comparison of results
between the test group sensitized to Df and the control
group (both sub-group healthy dogs and sub-group cAD),
yielded significant differences (in both cases P < 0.001, two-
sided Fisher’s exact test). Similarly, the test group sensitized
to Dp yielded the same results when compared with both
control sub-groups (P < 0.001, two-sided Fisher’s exact
test).
The diagnostic sensitivity and specificity of CPT for dust
mite Df were, respectively 91.7% (95% CI 67.8 to 99.3%)
and 95.8% (95% CI 83.9 to 99.6%). The corresponding
positive predictive value (PPV) was 91.7% (95% CI 67.8 to
99.3%) and the negative predicted value (NPV) was 95.8%
(95% CI 83.9 to 99.6%). The same calculations performed
for diagnostic CPT for Dp yielded: a sensitivity of 83.3%
(95% CI 58.9 to 91.2%), a specificity of 95.8% (95% CI
83.6 to 99.8%), a PPV of 90.9% (95% CI 64.2 to 99.5%)
and a NPV of 92% (95% CI 80.3 to 95.8%).
The majority of animals (71%, 15/21) had positive CPT
only with the most concentrated solution (2 BU/mL), four
scored positive with the medium dilution (0.4 BU/mL)
while only two scored positive with the mildest dilution
(0.08 BU/mL).
Detailed information on the results obtained in the test
group can be seen in Fig. 4. In Fig. 5, we can see an example
of a positive CPT in a sensitized atopic dog.
CPTs side effects
Adverse side effects were noticed only in two animals from
the test group sensitized to Df (8%; 2/24). These dogs
showed a sudden exacerbation of their atopic state (a flare),
and were observed again by clinicians from both ophthal-
mology and dermatology departments. Both dogs had
marked increases on CADESI-03 and pruritus (ocular and
global). In both cases, the dogs had initial CADESI-03 val-
ues compatible with severe disease (CADESI-03 of 126 and
153) and an ocular score of 5 and 7 and no corneal involve-
ment in any of the cases). An oral anti-inflammatory therapy
was prescribed (Prednisolone, 1 mg/kg/SID, 5 days) and
3 days after the episode they were both controlled and ther-
apy was discontinued. No other dogs showed any side effect.
DISCUSSION
Canine atopic dermatitis is a common condition in dogs and
its prevalence seems to be increasing over the last decades.
Overall, the exact prevalence of allergic conjunctivitis in
cAD is unknown. According to our results, cAD concomi-
tant eye allergy is more frequent than mentioned in the liter-
ature,18 and its prevalence seem to be strongly influenced by
the veterinarian’s individual area of specialization.
This results resemble those observed by Bonini regarding
medical class.5 Conjunctivitis prevalence among human
allergic patients seems highly dependent on the doctors’
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Figure 1. Ocular signs score in cDA patients (n = 60). The graphic
shows the percentage and the number of animals graded as mild (score
1), moderate (score 2) or severe (score 3).
Figure 2. Signs of active allergic blepharitis and conjunctivitis:
periocular alopecia and congestion, blepharitis and epiphora in the right
eye of an atopic dog with ocular pruritus. Clinical ocular score of 8. CAD-
ESI-03 of 30, compatible with a mild canine atopic dermatitis (cAD).
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speciality. In an unpublished study by Bonini and collabora-
tors, 2206 allergic human patients were observed by aller-
gists, dermatologists, ophthalmologists and pneumologists,
according to a specialist approach. For the same patients,
diagnosis of conjunctivitis was made in 45% (allergists),
10% (dermatologists), 90% (ophthalmologists) and 25%
(pneumologists) of the patients. Clearly, the variety of
results reflects individual main professional focus.
It is possible that allergic conjunctivitis in cAD is also
underreported. Maybe nondermatologic signs are sometimes
missed or under valuated as most dogs with cAD are seen by
general physicians or dermatologists and not by ophthalmol-
ogists. Also, attention can be distracted from the eye due to
more severe skin signs. Additionally, ocular pruritus can be
difficult to evaluate, both by owners and veterinarians, as
dogs with cAD usually tend to rub or scratch the face also due
to ear, muzzle and perilabial pruritus, making it difficult to
point the finger. Lastly, the majority of cAD patients are
medicated with systemic anti-inflammatory (corticosteroid
and cyclosporine) therapeutics which will also control
allergic ocular signs.
We believe that the existence of standardized criteria
available to general veterinary physicians and dermatologists
would allow them to correctly and easily diagnose allergic
conjunctivitis, especially in those cases that do not need an
ophthalmologic referral.
Our results show a correlation between the severity of
ocular signs and both eye pruritus and skin lesions score for
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Figure 4. Initial and final score values obtained on conjunctival provocation tests (CPTs) for Dermatophagoides farinae (Df, n = 12) and
Dermatophagoides pteronyssinus (Dp, n = 12) in sensitized canine atopic dermatitis (cAD) patients.
Figure 3. Right and left eye of a severely affected
atopic dog with periocular alopecia and congestion
due to blepharitis with intense pruritus and conjunc-
tival hyperemia, congestion and chemosis. Below we
can see the result of the intense pruritus with licking
dermatitis and self excoriations lesions in the poster-
ior paws of the same patient and an example of a
positive intradermal skin test. Clinical ocular score
of 10. CADESI-03 of 350, compatible with severe
canine atopic dermatitis (cAD).
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the head: ocular pruritus can indirectly result in more severe
skin lesions for that area.
Overall severity of cAD global skin lesions did not corre-
late with the severity of ocular signs or pruritus, so we could
not find any association between severe form of dermatitis
and conjunctivitis. It is possible that certain areas of the body
are ‘pre-programmed’ to develop inflammation upon aller-
gen challenge once sensitization has occurred.27 This may
be individually tailored to some extent, with some patients
developing more important skin or eye signs. People sensi-
tized for the same allergens will respond with dermatitis,
rhinitis, conjunctivitis or an association of these. We believe
this can also be the case in dogs.
We took 24 cAD sufferers with Dp or Df sensitization, we
performed CPT for both dust mites and we compared the
results obtained in the test group with a control group of
healthy dogs and atopic dogs without dust mite sensitivity. A
very significant relation (P < 0.001; Fisher exact test) was
found between the presence of dust mite sensitization and
positive CPT, showing a causal relationship between these
allergens and the ocular signs in these patients.
The diagnostic sensitivities and specificities for each CPT
(Dp and Df) were high, and similar to what was found by
others for humans.28
Results from a recent study done with high IgE-produc-
ing Beagle dogs (an experimental model for atopic dermati-
tis, sensitized both to Dp and Df, corroborate our findings
that these allergens can, in sensitized individuals, originate
allergic conjunctivitis upon exposure. These dogs were
submitted to environmental, specific oral and epicutaneous
provocation tests with Dp and Df. Regardless of the route
used, all developed periocular eritema. Two of six dogs,
33% of the population studied, developed allergic conjuncti-
vitis after the environmental exposure.
We found CPT to be rapid and easy to perform, without
the need of sedation. Also, we think it can be considered an
innocuous provocation test, given some precaution mea-
sures are taken. In our case, all tests were performed in a hos-
pital environment and the animals were closely monitored
by two investigators (A.M. Martins and E. Delgado) for any
adverse reactions until 2 h after the test. Furthermore, a
drop of a potent topical corticosteroid was applied after the
test was completed to the allergen-tested eye.
Although every effort was taken to prevent side effects,
two dogs had a sudden exacerbation of their allergic diseases.
It is not possible to definitely conclude that the CPT was the
cause of their acute clinical deterioration, but knowing that
these dogs had been stable for some time, and no other con-
ditions changed, we suspect that some systemic absorption
of the allergens might have occurred and triggered the aller-
gic response. Even if uncommon, flares of atopic states have
been described in human after CPT.8 Besides the measures
already taken, we think it may be wise to provide the owner
with an oral form of corticosteroid to use in case of a flare
after the CPT, especially in patients with moderate to severe
forms of cAD.
We think absorption by the conjunctiva, as well as expo-
sure of the respiratory mucosa from nasal cavity to allergens
due to transport through the nasolacrymal duct, could result
in an increased allergen exposure. Several studies in people
point out that topical treatment for rhinitis allergy also ame-
liorates conjunctivitis symptoms and vice versa, advocating
for the importance of this communication route.4,29,30
Furthermore with CPT we were able to establish an etio-
logic relationship between ocular manifestations and spe-
cific mite sensitizations. With CPT, a link could be made
between conjunctival pathology and exposure to allergens
for which the patient is known to be sensitized. These tests
are considered specific, and are probably the simplest way
to confirm or rule out specific allergic components of
conjunctivitis. Further studies, namely with other allergens,
are warranted to evaluate CPT potential as a gold-standard
test for the etiologic diagnosis of allergic conjunctivitis in
the dog but CPT seems to be a promising tool for the etio-
logic diagnosis of allergic conjunctivitis in cAD patients,
especially for those with significant eye symptoms.The
identification of the cause of allergic conjunctivitis by CPT
Figure 5. Positive conjunctival provocation test (CPT) in a sensitized
atopic dog.
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will allow a better understanding of this disease, and opens
new therapeutic monitorization tools. This is especially
important for those patients that have essentially ocular
symptoms and are in need of chronic anti-inflammatory
treatment with topical or systemic forms of corticosteroids
or calcineurin inhibitors. It would be particularly interest-
ing to see if these patients could benefit from specific
immunotherapy.
The European Medicines Agency (EMA) states that for
human the CPT is a validated model for studying allergic
conjunctivitis.31 The provoked reaction can be used to eval-
uate any allergic topical ocular products, with the benefit of
the patient’s contralateral eye acting as his/her own con-
trol.31 Furthermore, the CPT evaluating the response to an
allergen challenge before and after the effect of an anti-
allergic agent as compared with placebo may be used as
supportive evidence for efficacy and to establish a dose effect
relationship.31 In fact, most of the knowledge on the efficacy
of certain drugs for eye allergy in human was obtained
through CPT.32 In our opinion, CPT should be evaluated as
a tool for the evaluation of the efficacy of topical ocular med-
ications for eye allergy in the dog as well.
Nevertheless further studies with larger populations and
other allergens are needed to completely establish the
usefulness of CPT in dogs with ocular allergy.
We strongly believe that cooperation between ophthal-
mologists and dermatologists would be of benefit for these
patients, resulting in a multifaceted comprehension of cAD,
especially the role of ocular signs as a co-morbility of cAD
and a better evaluation and control of their clinical signs,
including the use of topical ocular forms of therapy to help
control their itchy eyes, enhancing their quality of life.
Little is known about eye allergy in the dog. It seems to
have features that resemble their human counterparts, lifting
the veil for a possible suitable model for the study of this dis-
ease in human. But first, a better characterization of this dis-
ease in the dog is needed, and would probably benefit from
uniform diagnostic criteria and use of CPTs, maybe more
properly designated by conjunctival allergen tests.
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